The share of France's scientific publications among the world's top 10% most cited in infectious diseases is forecasted to experience minimal year-on-year variation from 2024 to 2028, starting from 10.2% in 2024 and stabilizing at 10.23% by 2028. In 2023, this share was at 10.0%, reflecting a modest upward trend. The compounded annual growth rate (CAGR) for this period indicates a marginal increase, suggesting a steady positioning of French research impact in the field of infectious diseases.
Future trends to watch for include potential shifts due to global health crises, changes in research funding, and international collaborations that could influence citation impact and the contribution of French publications to high-impact global research.
